Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod

NCT06356012 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

HSIL, High-Grade Squamous Intraepithelial Lesions
Vaginal Microbiome
Biomarkers

Interventions

DRUG: Imiquimod
PROCEDURE: Loop Electrosurgical Excision Procedure

Sponsor

Barretos Cancer Hospital

Collaborators

[object Object]
[object Object]
[object Object]